Disodium cromoglycate in the treatment of chronic proctitis.
- 1 July 1975
- Vol. 16 (7), 559-563
- https://doi.org/10.1136/gut.16.7.559
Abstract
The effect of topical disodium cromoglycate (DSCG) has been examined in 30 patients with chronic active proctitis using a double-blind crossover trial. Each treatment period was four weeks and patients were given DSCG 200 mg by enema twice daily and 100 mg orally three times each day. Twenty-six patients completed the trial successfully, 14 responded to DSCG treatment, two improved with placebo, and 10 responded to neither. Patients who responded to DSCG had significantly more eosinophils in their rectal biopsies than those who failed to respond and in some instances the counts were very high. The findings support the hypothesis than an allergic reaction is important in the pathogenesis of proctitis.Keywords
This publication has 22 references indexed in Scilit:
- DISODIUM CROMOGLYCATE IN GASTROINTESTINAL PROTEIN INTOLERANCEThe Lancet, 1973
- INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTSThe Lancet, 1968
- Histamine content of rectal mucosa in ulcerative colitis.Gut, 1967
- Circulating Antibodies to Dietary Proteins in Ulcerative ColitisBMJ, 1965
- Eosinophilia in Peripheral Blood and Inflammatory Exudate in Non‐specific ProctocolitisActa Medica Scandinavica, 1964
- Observations on idiopathic proctitisGut, 1962
- A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitisGut, 1962
- EOSINOPHIL LEUCOCYTES IN ULCERATIVE COLITISThe Lancet, 1959
- Suppository Treatment of Haemorrhagic ProctitisBMJ, 1959
- WHAT IS ULCERATIVE COLITIS ?The Lancet, 1953